Company Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States.
The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples.
In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs.
It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J.
Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
| Country | United States |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 130 |
| CEO | Sujal Patel |
Contact Details
Address: 2701 Eastlake Avenue East Seattle, Washington 98102 United States | |
| Phone | 206 333 2001 |
| Website | nautilus.bio |
Stock Details
| Ticker Symbol | NAUT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1808805 |
| CUSIP Number | 63909J108 |
| ISIN Number | US63909J1088 |
| Employer ID | 98-1541723 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Sujal M. Patel | Co-Founder, Chief Executive Officer, President, Secretary and Director |
| Dr. Parag Mallick Ph.D. | Co-Founder, Chief Scientist and Director |
| Kentaro Suzuki | Chief Marketing Officer |
| Anna Mowry | Chief Financial Officer and Treasurer |
| Matthew B. Murphy ESQ. | General Counsel |
| Gwen E. Weld | Chief People Officer |
| Dr. Subra Sankar Ph.D. | Senior Vice President of Product Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 4, 2026 | SCHEDULE 13D/A | Filing |
| Mar 4, 2026 | SCHEDULE 13D/A | Filing |
| Feb 26, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Nov 4, 2025 | 8-K | Current Report |
| Oct 28, 2025 | 10-Q | Quarterly Report |
| Oct 28, 2025 | 8-K | Current Report |
| Jul 31, 2025 | 10-Q | Quarterly Report |
| Jul 31, 2025 | 8-K | Current Report |